Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
What is an index reading in finance? It captures composite price movements, offering a snapshot of overall market sentiment at a given moment.
12,394 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
New Bank of America analysis suggests the miserable k-shaped economy might be fading as lower-income households incre...
Celebrity nights can teach real money lessons. This guide turns high-profile spending into practical budgeting tips y...
Lawmakers are weighing the price of a $300 billion fund to rebuild Iran after conflict. The outcome could reshape deb...
When public servants take on off-duty work, the way they’re paid can have real financial consequences. This article u...
A fresh OpenAI policy hire has warned that government monopoly over frontier AI testing could slow innovation and rai...
As inflation remains stubborn, Bank of America nudges its rate outlook higher, forecasting three quarter-point Fed hi...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
SpaceX sits at the frontier of aerospace and opportunity. This article breaks down the bold bets, the potential rewar...
Northern Michigan families learned a hard lesson: being outside a flood zone on paper did not protect homes from a sp...
Two very different tech plays collide in 2026: Innodata edges into AI data preparation, while Workiva anchors large e...
Celebrity engagements often trigger more than wedding planning. This piece breaks down the financial implications of ...